ANNAPOLIS, MD - November 12, 2013 (Investorideas.com renewable energy stocks newswire) Solar Wind Energy Tower, Inc. (OTCQB: SWET) (the "Company"), the inventor of a large Solar Wind Downdraft Tower structure capable of producing abundant, inexpensive electricity, announced today that it has entered into a Memorandum of Understanding with Monsoon Global Group, LLC, which grants Monsoon Global a "Exclusivity Period" for rights to license trade secrets, patents, and knowledge from Solar Wind Energy. During the "Exclusivity Period" Monsoon has the exclusive right to "hold itself out in Rajasthan, India" to enter into long term "Definitive Agreement" with Solar Wind Energy to use the rights to develop Solar Wind Energy Downdraft Towers in Rajasthan, India.

Read more: Renewable Energy Stock Alert: Solar Wind Energy Tower, Inc. (SWET) Extends Rights to Develop...

SAN JOSE, Calif. - November 11, 2013 (Investorideas.com Newswire) Synaptics Inc. (SYNA), a leader in human interface solutions, announced Friday it has completed its acquisition of Validity Sensors, Inc. ("Validity") on November 7, 2013. Expansion into the fingerprint identification market, with the acquisition of a world class Validity team that delivers industry-leading solutions, is an integral part of Synaptics' growth strategy as it immediately expands the depth and breadth of solutions available to its global partners.

Read more: Biometric Stock Alert: Synaptics (SYNA) Closes Acquisition of Validity Sensors

 SAN DIEGO - November 7, 2013 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), announced today that Company Chairman and CEO, Jim Joyce will present a corporate overview at the SeeThruEquity Investor Conference on November 12th at 10:30 am Eastern Standard Time (EST). Mr. Joyce's presentation will be webcast via the following link: http://wsw.com/webcast/seethru5/AEMD. The conference will be held at Convene Midtown East (730 Third Avenue), New York City. Additional details can be accessed online at: www.seethruequity.com

Aethlon is currently preparing to launch the first U.S. studies of Hemopurifier® therapy based on the recent approval of an Investigational Device Exemption (IDE) by the United States Food and Drug Administration (FDA) to initiate feasibility studies in Hepatitis C (HCV) infected individuals.

Read more: Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) to Present at SeeThruEquity...

 MONTREAL - November 6, 2013 (Investorideas.com Mining stocks newswire) DNA Precious Metals, Inc. (DNAP) announces that the Company has closed an agreement to acquire the complete geological data resource on the Montauban Mine, in addition to its October 22, 2013 press released "Binding Agreement to acquire an undivided one hundred percent (100%) interest for all of the Montauban Mine Property located in Notre-Dame-de-Montauban, Quebec, Canada".

The geological data, dating from the start of production in 1914 to the last exploration in 2011, consists of over 1000 reports, drill logs, geological maps of near surface deposits, maps of underground mine workings, digital files and a Gemcom modeling of the mine.

Read more: Mining Stock Alert: DNA Precious Metals, Inc. (OCTQB: DNAP) Acquires the Complete Geological Data...

 November 6, 2013 (Investorideas.com biometrics/ defense stocks newswire) SeekingAlpha.com: SoundView Technology Group issues equity research note - NXT-ID (OTCQB: NXTD) Mobile-Bio Platform Enables M-Commerce.

Technology is finally enabling bio-based security features on mobile devices that will overcome one of the final obstacles to truly mobile digital commerce. One company, NXT-ID (OTC:NXTD), has emerged as a newly public company with a set of technologies and an open platform that can be used across all these applications. Based on our analysis the next few quarters of adoption will drive a near-term intrinsic value of over $10/share and a much higher figure for 2014. This report goes into more detail concerning the technology, the market, and the company.

Read more: Equity Research: NXT-ID (OTCQB:NXTD) Mobile-Bio Platform Enables M-Commerce